By Sabela Ojea
Spectral AI said Michael DiMaio is taking back the chairman of the board position.
The Dallas-based predictive AI company focused on medical diagnostics on Monday said that the board concluded it needed DiMaio's expertise to lead the next stage of growth of the company.
"Our focus will be on commercialization, Food and Drug Administration approval, our exceptional relationship with the Biomedical Advanced Research and Development Authority, and developing key strategic relationships," DiMaio said.
DiMaio is founded Spectral AI in 2009, served as the chief executive officer and chairman from 2011 to 2020. He is also company's second-largest shareholder.
Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix
(END) Dow Jones Newswires
October 14, 2024 16:19 ET (20:19 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。